gw8510 and su 9516

gw8510 has been researched along with su 9516 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buckner, FS; Domostoj, MM; Gelb, MH; Gillespie, JR; Napuli, AJ; Ojo, KK; Riechers, AJ; Scheer, A; Van Voorhis, WC; Verlinde, CL; Wells, SJ; Wells, TN1
Gucký, T; Hendrychová, D; Jorda, R; Kryštof, V; Řezníčková, E; Voller, J1

Other Studies

2 other study(ies) available for gw8510 and su 9516

ArticleYear
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Animals; Base Sequence; DNA Primers; DNA, Protozoan; Genes, Protozoan; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Protein Kinase Inhibitors; Recombinant Proteins; RNA Interference; Species Specificity; Trypanosoma brucei brucei; Trypanosomiasis, African

2008
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
    Journal of medicinal chemistry, 2018, 10-25, Volume: 61, Issue:20

    Topics: Cell Cycle; Cyclin-Dependent Kinases; HCT116 Cells; Humans; Protein Kinase Inhibitors; Quinolines; Thiazoles

2018